{
    "2018-07-27": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Top Stocks With High Dividend Yields",
                "features": {
                    "keywords": [
                        "high dividend yields",
                        "top stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividend-paying stocks"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Consumer Staples Select Sector SPDR Fund Experiences Big Inflow",
                "features": {
                    "keywords": [
                        "consumer staples",
                        "big inflow",
                        "spdr fund"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "consumer staples"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Recent Analysis Shows Synopsys, Rigel Pharmaceuticals, Fate Therapeutics, Philip Morris International, Sally Beauty, and Kimberly-Clark Market Influences â€” Renewed Outlook, Key Drivers of Growth",
                "features": {
                    "keywords": [
                        "synopsys",
                        "rigel pharmaceuticals",
                        "fate therapeutics",
                        "philip morris international",
                        "sally beauty",
                        "kimberly-clark",
                        "renewed outlook",
                        "growth drivers"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "consumer goods",
                        "tobacco"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}